Lac Acquires Masquelier’s® French Pine Bark Extract as Regional Expansion Accelerates

The V3 Group health and wellness brand adds more than 70 years of European nutritional science to its portfolio while growing across Asia and international markets.

LAC Global is strengthening both its product portfolio and international ambitions with the acquisition of MASQUELIER’S® French Pine Bark Extract, bringing decades of European nutritional science under the Singapore-headquartered health and wellness brand.

Parent company V3 Group Limited announced on August 18, 2026 that LAC had completed the acquisition, including MASQUELIER’S® patented technology and scientific heritage associated with oligomeric proanthocyanidins, or OPCs.

The deal comes as LAC continues to expand its retail and e-commerce presence across Asia and other international markets, including the Philippines.

Adding decades of nutritional science

MASQUELIER’S® traces its roots to the work of French scientist Professor Jack Masquelier, known for his research and development involving OPCs.

According to the company, the brand is distinguished by its proprietary extraction expertise and decades of research into the antioxidant properties of OPCs, supported by clinical studies.

For LAC, the acquisition goes beyond adding another supplement to its shelves.

It also brings the intellectual property and scientific background behind MASQUELIER’S® into the company’s wider health and wellness portfolio.

MASQUELIER’S® is also the originator and trademark holder of MASQUELIER’S® Anthogenol, an OPC supplement brand sold across Asia Pacific.

The release states that MASQUELIER’S® French Pine Bark Extract has sold more than 250 million tablets to date, making it one of LAC’s significant and longstanding product platforms across its Asian markets.

Building a wellness brand from Asia

V3 Group Founder and Executive Chairman Ron Sim said the acquisition strengthens the scientific foundation of LAC’s portfolio as consumers place greater attention on health and wellness.

He also emphasized Singapore’s continuing role as the company’s home market while LAC expands into new territories.

The broader ambition, according to the group, is to build a health and wellness brand created in Asia that can serve consumers globally.

That strategy is already reflected in LAC’s growing footprint.

The company now operates more than 250 retail stores across Singapore, Malaysia, the Philippines, Taiwan, Hong Kong and Vietnam.

Its presence is complemented by franchise operations in Mongolia, India, Indonesia and Thailand, as well as a growing e-commerce business.

Outside Asia, LAC products are also available in select markets across Africa, the Middle East and South America.

Expansion meets changing consumer priorities

LAC says its regional expansion is being driven by long-term changes in how consumers approach wellness, including ageing populations, greater health awareness and increasing spending on everyday wellness.

The company plans to deepen its presence in existing markets while exploring additional growth opportunities across Asia Pacific and internationally.

Alongside geographic expansion, LAC said it will continue investing in product development and science-backed nutritional solutions, with areas of focus including preventive health, healthy ageing and evolving consumer wellness needs.

V3 Group, meanwhile, will support LAC’s growth through capital, operational capabilities and regional connectivity.

Why the acquisition matters

For LAC, acquiring MASQUELIER’S® gives the company more than a recognizable product name.

It adds intellectual property, a long-established scientific heritage and an existing product platform at a time when the brand is trying to reach more consumers across multiple regions.

For markets such as the Philippines, where LAC already maintains a retail presence, the acquisition also signals how the company intends to strengthen its portfolio as it grows.

The larger story is one of scale meeting specialization: an Asia-based wellness retailer expanding internationally while investing in established nutritional science to support the next stage of its growth.